Trials that use: Covariate adjustment
4,539 results
- Flumazenil for the Treatment of Primary Hypersomnia: Complete Statistical AnalysisIndependent statistical analysis of Flumazenil for the Treatment of Primary Hypersomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183312).
- Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00695318).
- FLUORESCEIndependent statistical analysis of Fluoxetine for Visual Recovery After Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02737930).
- Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters: Complete Statistical AnalysisIndependent statistical analysis of Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02678039).
- Fluticasone Nasal Spray Patient Preference Study: Complete Statistical AnalysisIndependent statistical analysis of Fluticasone Nasal Spray Patient Preference Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00398476).
- FMBI With War-affected Families: Complete Statistical AnalysisIndependent statistical analysis of FMBI With War-affected Families: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05241314).
- FMT for FIIndependent statistical analysis of Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): Complete Statistical AnalysisIndependent statistical analysis of Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00135811).
- FOCUSIndependent statistical analysis of A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FOCUSIndependent statistical analysis of An Efficacy and Safety Study of Fremanezumab in Adults With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FOGIndependent statistical analysis of Amyloidopathy, Cholinopathy, Dopamine Responsiveness and Freezing of Gait in PD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03647137).
- Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor: Complete Statistical AnalysisIndependent statistical analysis of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor: primary endpoint results, effect estimate with confidence interval,…
- Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling: Complete Statistical AnalysisIndependent statistical analysis of Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04341363).
- Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas: Complete Statistical AnalysisIndependent statistical analysis of Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or Lymphomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Food Swaps to Improve the Healthfulness and Reduce the Carbon Footprint of Grocery Purchases: Complete Statistical AnalysisIndependent statistical analysis of Food Swaps to Improve the Healthfulness and Reduce the Carbon Footprint of Grocery Purchases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models: Complete Statistical AnalysisIndependent statistical analysis of Forced-air Warming in Endovascular Surgery: Testing Effectiveness of Two Different Blanket Models: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FORESTIndependent statistical analysis of Family History and Cancer Risk Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05079334).
- FORTRESSIndependent statistical analysis of Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267): Complete Statistical AnalysisIndependent statistical analysis of FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01065779).
- FPSIndependent statistical analysis of Effects of Obesity Treatments on Food Preferences and Metabolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01724060).
- Fracture Risk With Thiazolidinediones: Complete Statistical AnalysisIndependent statistical analysis of Fracture Risk With Thiazolidinediones: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01055223).
- FREAPIndependent statistical analysis of Effectiveness of Standardized Respiratory Physiotherapy in Primary Care (FREAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01152762).
- FREEDOMS IIIndependent statistical analysis of Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FREESIAIndependent statistical analysis of Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV): primary endpoint results, effect…
- FRESHIndependent statistical analysis of FRESH Study (Fitness, Relaxation and Eating to Stay Healthy): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01636258).
- Fresh Versus Old Red Blood Cells for Transfusion: Complete Statistical AnalysisIndependent statistical analysis of Fresh Versus Old Red Blood Cells for Transfusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01319552).
- Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): Complete Statistical AnalysisIndependent statistical analysis of Frespaciguat (MK-5475) in Participants With Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease (PH-COPD) (MK-5475-006): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- From Innovation to Solutions: Childhood Influenza Vaccination Planning: Complete Statistical AnalysisIndependent statistical analysis of From Innovation to Solutions: Childhood Influenza Vaccination Planning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664793).
- FRONTIERIndependent statistical analysis of Ferric Citrate for the Prevention of Renal Failure in Adults With Advanced Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FROZEN-AFIndependent statistical analysis of Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FSHDIndependent statistical analysis of Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: Complete Statistical AnalysisIndependent statistical analysis of Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00543127).
- Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Functional Electrical Stimulation (FES) for Upper Extremity Recovery in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142792).
- Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke: Complete Statistical AnalysisIndependent statistical analysis of Functional Electrical Stimulation Mediated Neuroplasticity: Lower Extremity CCNMES in Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02199795).
- Functional Rehabilitation of Older Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Functional Rehabilitation of Older Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00237796).
- Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT): Complete Statistical AnalysisIndependent statistical analysis of Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FX-LEARNIndependent statistical analysis of AFQ056 for Language Learning in Children With FXS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02920892).
- G-BMTIndependent statistical analysis of Buprenorphine Group Medical Visits in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02526212).
- G-MINORIndependent statistical analysis of Genomics in Michigan Impacting Observation or Radiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02783950).
- G2YMIIndependent statistical analysis of Getting to Yes, Michigan! (G2YMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05096260).
- Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): Complete Statistical AnalysisIndependent statistical analysis of Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01138124).
- Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients: Complete Statistical AnalysisIndependent statistical analysis of Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420771).
- GAINIndependent statistical analysis of Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GAINS-2Independent statistical analysis of A Brief Cognitive Task Intervention for NHS Staff Affected by COVID-19 Trauma (GAINS-2 Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GALAComplete statistical analysis of the phase 3 GALA trial of glatiramer acetate 40 mg three times weekly versus placebo in relapsing-remitting multiple sclerosis, including trial design, relapse endpoints, MRI outcomes, statistical methodology,…
- GALACTIC-HFIndependent statistical analysis of GALACTIC-HF, the randomized phase 3 trial of omecamtiv mecarbil in chronic heart failure with reduced ejection fraction, including time-to-event methods, KCCQ analysis, confidence intervals, multiplicity, and safety.
- GalaNicIndependent statistical analysis of Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02420327).
- Galantamine Effects on Cognitive Function in Abstinent Cocaine Users: Complete Statistical AnalysisIndependent statistical analysis of Galantamine Effects on Cognitive Function in Abstinent Cocaine Users: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00606801).
- Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03803475).
- GAM 10-06Independent statistical analysis of Non-Interventional Study on the Tolerability and Efficacy of IVIG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02303093).